The association between premorbid beta blocker exposure and mortality in sepsis-a systematic review.

Tan, Kaiquan; Harazim, Martin; Tang, Benjamin; Mclean, Anthony; Nalos, Marek

Tan, Kaiquan; Harazim, Martin; Tang, Benjamin; Mclean, Anthony; Nalos, Marek.

Afiliação

Tan K; Nepean Clinical School, Sydney Medical School, University of Sydney, Penrith, Australia.
Harazim M; Medical Intensive Care Unit, Teaching Hospital and Biomedical Centre, Charles University, Alej Svobody 80, 323 00, Pilsen, Czech Republic.
Tang B; Nepean Clinical School, Sydney Medical School, University of Sydney, Penrith, Australia.
Mclean A; Centre for Immunology and Allergy Research, Westmead Millennium Institute, Westmead, Australia.
Nalos M; Nepean Clinical School, Sydney Medical School, University of Sydney, Penrith, Australia.

Crit Care ; 23(1): 298, 2019 Sep 04.

Article em En | MEDLINE | ID: mdl-31484576

Assuntos

Antagonistas Adrenérgicos beta/efeitos adversos; Hipertensão/tratamento farmacológico; Sepse/mortalidade; Antagonistas Adrenérgicos beta/farmacologia; Antagonistas Adrenérgicos beta/uso terapêutico; Humanos; Hipertensão/mortalidade; Estudos Retrospectivos; Sepse/fisiopatologia

Palavras-chave

Beta blockers; Mortality; Sepsis; Systematic review

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sepse / Antagonistas Adrenérgicos beta / Hipertensão Tipo de estudo: Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google